Literature DB >> 22875277

α-Ketoglutarate-related inhibitors of HIF prolyl hydroxylases are substrates of renal organic anion transporters 1 (OAT1) and 4 (OAT4).

Yohannes Hagos1, Gunnar Schley, Johannes Schödel, Wolfgang Krick, Gerhard Burckhardt, Carsten Willam, Birgitta C Burckhardt.   

Abstract

2-Oxoglutarate or α-ketoglutarate (αKG) is a substrate of HIF prolyl hydroxylases 1-3 that decrease cellular levels of the hypoxia-inducible factor 1α (HIF-1α) in the presence of oxygen. αKG analogs are applied to stabilize HIF-1α even in the presence of oxygen and thus provide a novel therapeutic option in treating kidney diseases. In the kidneys, the organic anion transporters 1 and 3 (OAT1 and OAT3, respectively) in cooperation with the sodium-dependent dicarboxylate transporter 3 (NaDC3) and the OAT4 might be responsible for the uptake of αKG analogs into and the efflux out of the tubular cells. Using the radiolabelled substrates p-aminohippurate (PAH, OAT1), estrone-3-sulfate (ES; OAT3, OAT4), and succinate (NaDC3), N-oxalylglycine (NOG), dimethyloxalyl glycine (DMOG), 2,4-diethylpyridine dicarboxylate (2,4-DPD), and pyridine-2,4-dicarboxylic acid (PDCA) were tested in cis-inhibition and trans-stimulation experiments. None of these αKG analogs interacted with NaDC3. 2,4-DPD and PDCA inhibited ES uptake by OAT3 moderately. NOG, 2,4-DPD and PDCA, but not DMOG, inhibited PAH uptake by OAT1 significantly. trans-Stimulation experiments and experiments demonstrating stabilization of HIF-1α revealed that NOG and PDCA, but not 2,4-DPD, are translocated by OAT1. All compounds trans-stimulated ES uptake by OAT4, but only PDCA stabilized HIF-1α. The data suggest that OAT1 is involved in the uptake of NOG and PDCA across the basolateral membrane of proximal tubule cells, whereas OAT4 may release these compounds into the primary urine.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22875277     DOI: 10.1007/s00424-012-1140-9

Source DB:  PubMed          Journal:  Pflugers Arch        ISSN: 0031-6768            Impact factor:   3.657


  27 in total

1.  Gene expression levels and immunolocalization of organic ion transporters in the human kidney.

Authors:  Hideyuki Motohashi; Yuji Sakurai; Hideyuki Saito; Satohiro Masuda; Yumiko Urakami; Maki Goto; Atsushi Fukatsu; Osamu Ogawa; Ken-Ichi Inui
Journal:  J Am Soc Nephrol       Date:  2002-04       Impact factor: 10.121

2.  Differential interaction of dicarboxylates with human sodium-dicarboxylate cotransporter 3 and organic anion transporters 1 and 3.

Authors:  Marcel Kaufhold; Katharina Schulz; Davorka Breljak; Shivangi Gupta; Maja Henjakovic; Wolfgang Krick; Yohannes Hagos; Ivan Sabolic; Birgitta C Burckhardt; Gerhard Burckhardt
Journal:  Am J Physiol Renal Physiol       Date:  2011-08-24

3.  The tumour suppressor protein VHL targets hypoxia-inducible factors for oxygen-dependent proteolysis.

Authors:  P H Maxwell; M S Wiesener; G W Chang; S C Clifford; E C Vaux; M E Cockman; C C Wykoff; C W Pugh; E R Maher; P J Ratcliffe
Journal:  Nature       Date:  1999-05-20       Impact factor: 49.962

4.  Targeting of HIF-alpha to the von Hippel-Lindau ubiquitylation complex by O2-regulated prolyl hydroxylation.

Authors:  P Jaakkola; D R Mole; Y M Tian; M I Wilson; J Gielbert; S J Gaskell; A von Kriegsheim; H F Hebestreit; M Mukherji; C J Schofield; P H Maxwell; C W Pugh; P J Ratcliffe
Journal:  Science       Date:  2001-04-05       Impact factor: 47.728

5.  HIFalpha targeted for VHL-mediated destruction by proline hydroxylation: implications for O2 sensing.

Authors:  M Ivan; K Kondo; H Yang; W Kim; J Valiando; M Ohh; A Salic; J M Asara; W S Lane; W G Kaelin
Journal:  Science       Date:  2001-04-05       Impact factor: 47.728

6.  Preconditional activation of hypoxia-inducible factors ameliorates ischemic acute renal failure.

Authors:  Wanja M Bernhardt; Valentina Câmpean; Sarah Kany; Jan-Steffen Jürgensen; Alexander Weidemann; Christina Warnecke; Michael Arend; Stephen Klaus; Volkmar Günzler; Kerstin Amann; Carsten Willam; Michael S Wiesener; Kai-Uwe Eckardt
Journal:  J Am Soc Nephrol       Date:  2006-06-08       Impact factor: 10.121

Review 7.  Hypoxia-inducible factor 1 (HIF-1) pathway.

Authors:  Gregg L Semenza
Journal:  Sci STKE       Date:  2007-10-09

Review 8.  Hypoxia-inducible factors in the kidney.

Authors:  Volker H Haase
Journal:  Am J Physiol Renal Physiol       Date:  2006-03-22

Review 9.  Drug discovery for overcoming chronic kidney disease (CKD): prolyl-hydroxylase inhibitors to activate hypoxia-inducible factor (HIF) as a novel therapeutic approach in CKD.

Authors:  Tetsuhiro Tanaka; Masaomi Nangaku
Journal:  J Pharmacol Sci       Date:  2009-01       Impact factor: 3.337

10.  Human organic anion transporter 4 is a renal apical organic anion/dicarboxylate exchanger in the proximal tubules.

Authors:  Sophapun Ekaratanawong; Naohiko Anzai; Promsuk Jutabha; Hiroki Miyazaki; Rie Noshiro; Michio Takeda; Yoshikatsu Kanai; Samaisukh Sophasan; Hitoshi Endou
Journal:  J Pharmacol Sci       Date:  2004-03       Impact factor: 3.337

View more
  3 in total

Review 1.  Disrupted Alpha-Ketoglutarate Homeostasis: Understanding Kidney Diseases from the View of Metabolism and Beyond.

Authors:  Lijing Guo; Shihua Chen; Liping Ou; Shangmei Li; Zhen-Nan Ye; Hua-Feng Liu
Journal:  Diabetes Metab Syndr Obes       Date:  2022-06-27       Impact factor: 3.249

2.  Evaluation of Renal Anionic Secretion Following Living-donor and Deceased-donor Renal Transplantation: A Clinical Pharmacokinetic Study of Cefoxitin Microdosing.

Authors:  Hari V Kalluri; Puneet Sood; Wenchen Zhao; Parmjeet S Randhawa; Amit D Tevar; Sundaram Hariharan; Abhinav Humar; Raman Venkataramanan
Journal:  Transplant Direct       Date:  2020-05-28

3.  Substrate-Dependent Trans-Stimulation of Organic Cation Transporter 2 Activity.

Authors:  Charles R Lefèvre; Marc Le Vée; Sophie Gaubert; Elodie Jouan; Arnaud Bruyere; Caroline Moreau; Olivier Fardel
Journal:  Int J Mol Sci       Date:  2021-11-29       Impact factor: 5.923

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.